SecBot SecBot
8-K ·Filed May 1, 2026

CNTX

Context Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001628280-26-029323
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

This is a routine litigation resolution with no material financial impact. Monitor the annual meeting on June 24, 2026 for final closure. No trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CNTX ▼ -73.17% at T+60d
NEUTRAL call -73.17% · α vs SPY -75.03% · entry $2.30 → $0.6170
Entry = T+0 close
May 1, 2026
via day close
T+1d
+6.09%
call +6.09% · α +5.29%
$2.44
settled 6mo ago
T+5d
+3.91%
call +3.91% · α +0.98%
$2.39
settled 6mo ago
T+20d
+21.30%
call +21.30% · α +15.66%
$2.79
settled 5mo ago
T+60d
-73.17%
call -73.17% · α -75.03%
$0.6170
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Context Therapeutics resolved a stockholder class action lawsuit challenging its charter provisions. Under a court-approved settlement, a third-party provider paid the $850,000 mootness fee on the company's behalf, and the case will close after the 2026 annual meeting. The financial impact is immaterial (0.39% of market cap) and the charter provisions have already been corrected.

Key Facts

  • Court invalidated charter provisions regarding three-year director terms and removal only for cause; company filed certificate of correction.
  • $850,000 mootness fee paid in full by a third-party service provider on May 1, 2026.
  • Lawsuit dismissed with prejudice; court retains jurisdiction only for fee application.
  • Case to close after company's 2026 annual meeting (June 24, 2026) confirms quorum.

Financial Impact

No direct cost to company; $850,000 fee paid by third party; immaterial relative to $217M market cap.

Risk Factors

  • None material identified.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-029323
Document: 0001628280-26-029323-index-headers.html0001628280-26-029323
Document: 0001628280-26-029323-index.html0001628280-26-029323
Document: 0001628280-26-029323.txt0001628280-26-029323
7 reports for CNTX
Performance horizon
25% Hit rate @ T+5 1 of 4 directional calls Went positive at some point 1 of 4 best @ T+5▲ +22.33%May 18, 2026
Filters
Rows
Reports for CNTX — sortable, filterable
TypeNow
Jun 15, 2026
19w ago
8-K
BULLISH ★ 7/10
$0.6791 $0.6299▼ −7.24%▼ −5.86%$0.2347 (−65.44%)
Jun 15, 2026
19w ago
Press Release
BULLISH ★ 7/10
$0.6791 $0.6299▼ −7.24%▼ −5.86%$0.2347 (−65.44%)
May 18, 2026
23w ago
PRESS-RELEASE / 8-K
BULLISH ★ 7/10
$2.15 $2.63▲ +22.33%▲ +20.71%$0.2347 (−89.08%)
May 6, 2026
24w ago
Press Release
MIXED ★ 5/10
$2.33 $2.36▲ +1.29%▼ −0.22%$0.2347 (−89.93%)
May 1, 2026
25w ago
8-K
NEUTRAL ★ 2/10
$2.30 $2.39▲ +3.91%▲ +0.98%$0.2347 (−89.80%)
Apr 2, 2026
29w ago
8-K
BULLISH ★ 7/10
$2.72 $2.49▼ −8.46%▼ −12.07%$0.2347 (−91.37%)
Mar 23, 2026
31w ago
Press Release
MIXED ★ 5/10
$3.18 $2.62▼ −17.61%▼ −17.19%$0.2347 (−92.62%)
Showing 7 of 7

US Market Status

Market Closed — Opens Wed (15h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026